Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive study of three novel cases of TFEB‐amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome

11 Nov 2017

Abstract excerpt

The first case of TFEB-amplified renal cell carcinoma was published in 2014. Since then, 29 additional cases have been described. The prognostic and therapeutic implications of this rare entity remain to be determined. We describe here the clinical, histological, and genetic features of three novel cases, and the first complete literature review. Four tumors were examined from three patients selected from the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29127730
DOI: 10.1002/gcc.22513

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive study of three novel cases of TFEB‐amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcomePMID 29127730Read ↗

Clinicopathologic and Molecular Study of TFEB-altered Renal Cell CarcinomasSemantic proximity Read ↗

Comprehensive study of nine novel cases of TFEB ‐amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expressionSemantic proximity Read ↗

TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.Semantic proximity Read ↗

TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.Semantic proximity Read ↗

Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum.Semantic proximity Read ↗

The New WHO Category of “Molecularly Defined Renal Carcinomas”: Clinical and Diagnostic Features and Management ImplicationsSemantic proximity Read ↗

TFEB Expression Profiling in Renal Cell CarcinomasSemantic proximity Read ↗

Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical CourseSemantic proximity Read ↗

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular InsightsSemantic proximity Read ↗

MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current KnowledgeSemantic proximity Read ↗

Histological and molecular characterization of TFEB-rearranged renal cell carcinomasSemantic proximity Read ↗

TFEB-amplified Renal Cell CarcinomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.